H. References, Back to the index of the Guidance for the Notification of Serious Breaches of GCP or the Trial Protocol Version 6, 08 Jul 2020, MHRA

• Statutory instrument 2004/1031: The Medicines for Human Use (Clinical Trials) Regulations 2004 (https://www.legislation.gov.uk/uksi/2004/1031/pdfs/uksi_20041031_en.pdf).

• Statutory Instrument 2006/1928: The Medicines for Human Use (Clinical Trials) Amendment Regulations 2006 (https://www.legislation.gov.uk/uksi/2006/1928/pdfs/uksi_20061928_en.pdf).

• See also MHRA GCP Guide 2012 (https://www.gov.uk/guidance/good-clinical-practice-for-clinical-trials)

Back to the index of the Guidance for the Notification of Serious Breaches of GCP or the Trial Protocol Version 6, 08 Jul 2020, MHRA, Medicines & Healthcare products Regulatory Agency

 

Clinical Research News

No Invasive Breast Cancer Found After Surgery — but Tumor DNA Is Detectable. Should Treatment Intensify?
After a Heart Attack or Stent, Do Older Adults Need Lifelong Aspirin?
Could One Radiation Treatment Let Some Patients With Small Breast Cancer Avoid Lumpectomy?
Could a Monthly Shot Help Maintain Weight Loss After Wegovy or Zepbound?
Not another GLP-1: petrelintide moves into a 3,900-person Phase III obesity trial
Can varicose veins be treated without needles, catheters or heat? First-in-human study tests non-thermal focused ultrasound
One-time gene editing for high LDL enters Phase 2: can VERVE-102 deliver lasting cholesterol control?

Připravované klinické studie

Clinical Research Jobs

More jobs

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

Předplatit